Gene · 389
Papers2,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting the Isoprenoid Biosynthetic Pathway in Multiple Myeloma. | Int J Mol Sci | 2022 | 36613550 | PubTator, text mining | PubMed |
| MiR-302a Regenerates Human Corneal Endothelial Cells against IFN-γ-Induced Cell Death. | Cells | 2022 | 36611829 | PubTator, text mining | PubMed |
| Mechanism of Hypoxia-Mediated Smooth Muscle Cell Proliferation Leading to Vascular Remodeling. | Biomed Res Int | 2022 | 36593773 | PubTator, text mining | PubMed |
| The emerging role of miR-20b in human cancer and other disorders: Pathophysiology and therapeutic implications. | Front Oncol | 2022 | 36582800 | PubTator, text mining | PubMed |
| Recent Updates on the Role of the MicroRNA-10 Family in Gynecological Malignancies. | J Oncol | 2022 | 36578791 | PubTator, text mining | PubMed |
| RAC1, a Potential Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma. | Cells | 2022 | 36552804 | PubTator, text mining | PubMed |
| Embryonic organizer formation disorder leads to multiorgan dysplasia in Down syndrome. | Cell Death Dis | 2022 | 36535930 | PubTator, text mining | PubMed |
| Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer. | Nat Commun | 2022 | 36509758 | PubTator, text mining | PubMed |
| Oncolytic virus: A catalyst for the treatment of gastric cancer. | Front Oncol | 2022 | 36505792 | PubTator, text mining | PubMed |
| Identification of cuproptosis-related long noncoding RNA signature for predicting prognosis and immunotherapy response in bladder cancer. | Sci Rep | 2022 | 36496537 | PubTator, text mining | PubMed |
| Machine Learning Modeling of Protein-intrinsic Features Predicts Tractability of Targeted Protein Degradation. | Genomics Proteomics Bioinformatics | 2022 | 36494034 | PubTator, text mining | PubMed |
| Critical role of Rho proteins in myosin light chain di-phosphorylation during early phase of endothelial barrier disruption. | J Physiol Sci | 2022 | 36476233 | PubTator, text mining | PubMed |
| RhoC in association with TET2/WDR5 regulates cancer stem cells by epigenetically modifying the expression of pluripotency genes. | Cell Mol Life Sci | 2022 | 36469134 | PubTator, text mining | PubMed |
| The complex, dynamic SpliceOme of the small GTPase transcripts altered by technique, sex, genetics, tissue specificity, and RNA base editing. | Front Cell Dev Biol | 2022 | 36467401 | PubTator, text mining | PubMed |
| Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment. | Front Oncol | 2022 | 36457492 | PubTator, text mining | PubMed |
| Cofilin Acts as a Booster for Progression of Malignant Tumors Represented by Glioma. | Cancer Manag Res | 2022 | 36452435 | PubTator, text mining | PubMed |
| Whole-exome sequencing study identifies rare variants and genes associated with intraocular pressure and glaucoma. | Nat Commun | 2022 | 36450729 | PubTator, text mining | PubMed |
| Correction: miR-2682-3p antagonizes its host lncRNA-MIR137HG by interacting with the same target FUS to regulate the progression of gastric cancer. | BMC Cancer | 2022 | 36447179 | PubTator, text mining | PubMed |
| FMNL3 is Overexpressed in Tumor Tissues and Predicts an Immuno-Hot Phenotype in Pancreatic Cancer. | Int J Gen Med | 2022 | 36444244 | PubTator, text mining | PubMed |
| A novel prognostic model for prostate cancer based on androgen biosynthetic and catabolic pathways. | Front Oncol | 2022 | 36439479 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389/papers?page=13